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Abstract 
Proprotein convertases are enzymes that proteolytically cleave protein precursors in the 
secretory pathway to yield functional proteins. Seven mammalian subtilisin/Kex2p-like pro-
protein convertases have been identified: furin, PC1, PC2, PC4, PACE4, PC5 and PC7. The 
binding pockets of all seven proprotein convertases are evolutionarily conserved and highly 
similar. Among the seven proprotein convertases, the furin cleavage site motif has recently 
been characterized as a 20-residue motif that includes one core region P6–P2´ inside the 
furin binding pocket. This study extended this information by examining the 3D structural 
environment of the furin binding pocket surrounding the core region P6-P2´ of furin sub-
strates. The physical properties of mutations in the binding pockets of the other six mam-
malian proprotein convertases were compared. The results suggest that: 1) mutations at 
two positions, Glu230 and Glu257, change the overall density of the negative charge of the 
binding pockets, and govern the substrate specificities of mammalian proprotein convertases; 
2) two proprotein convertases (PC1 and PC2) may have reduced sensitivity for positively 
charged residues at substrate position P5 or P6, whereas the substrate specificities of three 
proprotein convertases (furin, PACE4, and PC5) are similar to each other. This finding led to 
a novel design of a short peptide pattern for small molecule inhibitors: [K/R]-X-V-X-K-R. 
Compared with the widely used small molecule dec-RVKR-cmk that inhibits all seven pro-
protein convertases, a finely-tuned derivative of the short peptide pattern [K/R]-X-V-X-K-R 
may have the potential to more effectively inhibit five of the proprotein convertases (furin, 
PC4, PACE4, PC5 and PC7) compared to the remaining two (PC1 and PC2). The results not 
only provide insights into the molecular evolution of enzyme function in the proprotein 
convertase family, but will also aid the study of the functional redundancy of proprotein 
convertases and the development of therapeutic applications.   
Key words: small molecular inhibitor; mammalian proprotein convertases; substrate specificity, 
evolution of gene family. 
1. Introduction 
In the secretory pathway, many secreted pro-
teins or transmembrane proteins are initially synthe-
sized as protein precursors and subsequently cleaved 
by proprotein convertases before they become fully 
functional. The cleavage of protein precursors by 
proprotein convertases is involved in the molecular Int. J. Biol. Sci. 2010, 6 
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pathogenesis of a wide range of human diseases in-
cluding cancer, neurological disorders, autoimmune 
diseases and various viral infections[1]. So far, seven 
mammalian subtilisin/Kex2p-like proprotein con-
vertases have been identified: furin, PC1/PC3/SPC3, 
PC2/SPC2, PC4/SPC5, PACE4/SPC4, 
PC5/PC6/SPC6 and PC7/PC8/SPC7/LPC. The 
binding pockets of all seven proprotein convertases 
are evolutionarily conserved and highly similar[2,3]. 
Among the seven mammalian proprotein converta-
ses, the cleavage of furin is the best characterized. The 
3D crystal structure of dec-RVKR-cmk inhibited 
mouse furin binding pocket has been solved by Hen-
rich and co-workers[4]. Furthermore, in authors’ re-
cent study, instead of a canonical four-residue motif 
R-X-[K/R]-R↓, the furin cleavage site has been char-
acterized as a 20-residue motif that can be divided 
into two parts with distinct physical properties: 1) a 
core region (8 amino acids, position P6–P2´) inside 
the furin binding pocket that contributes to the bind-
ing strength of the substrate and 2) two polar regions 
(8 amino acids, positions P7–P14; and 4 amino acids, 
positions P3´–P6´) outside the furin binding pocket 
that mainly contribute to the solvent accessibility of 
the substrate[5].   
The 3D structure of the furin binding pocket[4] 
and the physical properties of the core region P6–P2´ 
of the furin cleavage site motif[5] provide a template 
with which to compare the local structural–functional 
relationship of all mammalian proprotein converta-
ses. In this report, a multiple sequence alignment of 
mammalian proprotein convertases was generated, 
and the physical properties of mutations in the bind-
ing pockets were examined. The functional conse-
quences of mutations were interpreted using the 3D 
structure. The results indicated two residues that play 
a key role in regulation of the substrate specificity of 
mammalian proprotein convertases. This finding 
provides insights into the molecular evolution of the 
enzyme function of the proprotein convertase family. 
The comparison of 3D structures also suggested a 
novel design for specific small molecular inhibitors 
that will aid the study of the functional redundancy 
of mammalian proprotein convertases and the de-
velopment of therapeutic applications. 
2. Results and Discussion 
2.1. 3D Structural environment of binding pocket of furin 
The eight amino acids of the core region P6–P2´ 
of a furin substrate are located inside the furin bind-
ing pocket and are the main factor determining the 
binding strength of a substrate[5]. T h e  r e s i d u e s  o f  t h e  
mouse furin binding pocket surrounding the core 
region P6–P2´ of furin substrates was analyzed in the 
3D crystal structure of the dec-RVKR-cmk inhibited 
mouse furin binding pocket[4] and also in the au-
thors’ recent study on the furin cleavage site motif[5]. 
Table 1 lists the structural environment surrounding 
the substrate positions P6–P2´. 
Table 1. List of substrate positions and their inter-
acting residues in the mouse furin binding pocket, 
which explain the substrate specificity of furin and 
the favoured physical properties at substrate posi-
tion P6-P2’. The residues were retrieved from the 3D 
structure of the dec-RVKR-cmk inhibited mouse furin 
binding pocket (Protein Data Bank ID: IP8J)[4]. 
Substrate 
position 
Main interaction partners: residues and positions in 
the mouse furin binding pocket 
P1  His194 Ser253 Trp254 Gly255 Pro256 Glu257 Asp258 
Ala292 Ser293 Gly294 Asn295 Asp301 Asp306 Glu331 
Ser368 
P2  Asp153 Asp154 Asp191 Asn192 Arg193 His194 
P3   Leu227 Ser253 Trp254 Gly255 Pro256 Glu257 Asp258 
P4  Leu227 Asp228 Gly229 Glu230 Val231 Thr232 Asp233 
Glu236 Trp254 Gly255 Pro256 Glu257 Asp258 Asp264 
Gly265 Pro266 Ala267 
P5, P6  Leu227 Asp228 Gly229 Glu230 Val231 Thr232 Asp233 
Glu236 Trp254 Gly255 Pro256 Glu257 Asp264 Tyr308 
P1’  His194 Ser253 Gly294 Asn295 His364 Thr365 Gly366 
Thr367 Ser368 Ala369 
P2’  His194 Cys198 Ser253 Asn295 Ser319 Try329 Ser342 
Ser343 Ile351 His364 Thr365 Gly366 Thr367 Ser368 
Ala369 Ser370 Ala371 Pro372 
2.2. Comparison of the 3D structural environment of 
binding pockets of seven mammalian proprotein conver-
tases 
To study the substrate specificity of the other six 
proprotein convertases (PC1, PC2, PC4, PACE4, PC5 
and PC7), the 3D structural environments provided 
by these six different mammalian proprotein conver-
tases were compared against furin. A multiple se-
quence alignment of the binding pockets of seven 
mammalian proprotein convertases was generated 
using Clustalx[6] and are publicly available on the 
associated website www.nuolan.org. The residue po-
sitions (listed in Table 1) of the binding pockets sur-
rounding the core region P6–P2´ were examined in 
the multiple sequence alignment and mutations were 
identified (Figure 1) (Table 2). 
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Figure 1. Mutations in the key residues in the binding pockets of mammalian proprotein convertases. Black 
indicates conserved residues. Blue indicates that a mutation changes the amino acid type but does not significantly affect the 
physical properties of the side chain of an amino acid. Red indicates that a mutation affects the physical properties of the side 
chain of an amino acid. The multiple sequence alignment was generated with Clustalx[6]. 
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Generally, changes in amino acids at specific 
positions in the binding pockets can be classified into 
three types: 
1. Conserved. Marked in black in Figure 1, e.g. 
Asp153.  
2. Amino acid is mutated in one or more pro-
protein convertases, but the physical properties of the 
mutated amino acids can be considered as conserved 
and the favoured interaction between a substrate and 
a furin binding pocket at this position can still be 
maintained by the mutated amino acid in the 3D 
structure. These are marked in blue in Figure 1, e.g. 
Asp264->Glu264 in PC1. 
3. Amino acid is mutated in one or more pro-
protein convertases and the physical properties of the 
mutated amino acids are changed. These are marked 
in red in Figure 1, e.g. Glu230->Pro230 in PC7.   
Table 2. Comparison of binding pockets of mam-
malian proprotein convertases. Mutations in the key 
residues in the binding pocket of mammalian proprotein 
convertases are listed. Mutations in negatively charged 
Glu230 and Glu257 are repeatedly observed and high-
lighted in the table. Both of the negative charges at posi-
tions 230 and 257 are lost in the PC1 and PC2 binding 
pocket. * Mutation is not observed in all species. 
Proprotein convertase  Mutations in comparison with furin 
binding pocket 
PC1/PC3/SPC3  D191->E, R193->K, E230->I, 
E257->N, D264->E, A267->G, 
S343->G* 
PC2/SPC2  D191->F, R193->S, 
G229E230V231->QPFM, E257->T, 
A267->R, N295->D, S343->N, 
I351->V, T365->S, S370->A 
PC4/SPC5  D191->E, E230V231->A/T I, 
T232->S*, A267->G 
PACE4/SPC4  D191->E , R193 ->K, E230 ->D, 
E257->D, A267->G, A369->V 
PC5/PC6/SPC6  D191->E, R193->K, E230->D, 
E257->D 
PC7/PC8/SPC7/LPC  D191->G, R193->H, E230V231->PL, 
E257->D, A267->H, S319->A, 
S343->G, I351->T, S370->A 
 
 
It is striking that mutations in Glu230 or Glu257 
were repeatedly observed, these being key residues 
interacting with substrate positions P4–P6 (Figure 2). 
Two of the most notable features and interactions at 
substrate positions P4–P6 have been observed in pre-
vious experiments[2,3,7-9] and can be explained by 
the 3D structure in this region:   
1. Sensitivity to positive charge: a positively 
charged residue such as arginine and lysine at sub-
strate position P5 and P6 could increase the furin 
cleavage efficiency because it may interact with the 
n e g a t i v e l y  c h a r g e d  G l u 2 3 0  o r  G l u 2 5 7  o f  t h e  f u r i n  
binding pocket. 
2. Compensatory effect for positive charge: a 
positively charged residue such as arginine and ly-
s i n e  i s  f a v o u r e d  a t  s u b s t r ate position P4 because it 
may interact with the negatively charged Glu236 and 
Asp264 of the furin binding pocket. Loss of a posi-
tively charged residue at position P4 results in loss of 
favourable interactions between the positive charge 
and negative charge at substrate position P4. How-
ever, this loss can be compensated by the presence of 
a positively charged residue at substrate position P5 
or P6. Known furin cleavage sites with this compen-
satory effect for positive charges include integrin al-
pha 4 precursor (HVISKR597↓, GI_124945)[10], 
pro-parathyroid hormone (KSVKKR31↓, 
GI_4506267)[11], vascular endothelial growth factor C 
precursor (HSIIRR227↓, GI_1718154)[12], albumin 
precursor (RGVFRR24↓, GI_4502027)[13], furin 
auto-cleavage site (RGVTKR75↓, GI_120611)[14], vi-
tamin K-dependent protein C precursor (LRIRKR42↓, 
GI_131067)[15] and integral membrane protein 2B 
(KGIQKR243↓, GI_12643343)[16].   
It should be emphasized that what compensates 
for the loss of the positive charge at substrate position 
P4 is not the observed presence of a positive charge at 
substrate position P5 or P6, but the interaction force 
between the positive charge and negative charge 
formed at substrate position P5 or P6. Therefore, in 
order to maintain the sensitivity and compensatory 
effect of the positive charge at the substrate positions 
P4–P6, negatively charged residues are required in 
the binding pocket. Mutations in Glu230 or Glu257 
change the overall negatively charged density of the 
binding pockets of the other six mammalian propro-
tein convertases, with profound functional conse-
quences:  
1. For mammalian PC1 and PC2, mutations in 
Glu230 or Glu257 result in the loss of the negative 
charge at these two positions. As a consequence, a 
positively charged residue at the substrate position 
P5 or P6 cannot interact with the negatively charged 
residues at position 230 and 257 of the binding pock-
ets of PC1 and PC2, and therefore the presence of a 
positively charged residue at substrate position P5 
and P6 may not effectively contribute to the cleavage 
efficiency of PC1 or PC2. Moreover, the observed 
compensatory effect of the positive charge over sub-
strate positions P4–P6 on furin cleavage may be re-
duced for the cleavage of PC1 and PC2.   
2. For mammalian PC4 and PC7, mutation in 
G l u 2 3 0  r e s u l t s  i n  t h e  l o s s  o f  o n e  n e g a t i v e  c h a r g e .  
However, mutation in Glu257 was not observed in 
the PC4 binding pocket, and Glu257 is mutated to 
Asp257, which preserves the negative charge in the 
PC7 binding pocket. The consequence of the loss of Int. J. Biol. Sci. 2010, 6 
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only one negative charge at position 230 is not very 
clear.  
3. The mutations in the binding pocket of 
mammalian PACE4 and PC5 lead to residues with 
similar physical properties such as charge, hydro-
phobicity and volume. This suggests that of all the 
mammalian proprotein convertases, furin, PACE4 
and PC5 may have the closest substrate specificity.   
 
 
 
Figure 2. The sensitivity and the compensatory effect of the positive charge at substrate positions P4–P6 
require negatively charged residues in the binding pocket of mammalian proprotein convertases. At position 
P4, the positively charged residue arginine interacts with Glu236, Asp264, and Tyr308 of the furin binding pocket. Hydrogen 
bonds of molecular interactions at position P4 are calculated and shown as green lines. If a positively charged residue is 
absent at position P4 and favourable interactions with negatively charged Glu236 and Asp264 of the furin binding pocket are 
lost, this loss can be compensated for by the gain of an interaction between the negatively charged Glu230 and Glu257 of the 
binding pocket and a positively charged residue at substrate position P5 or P6. The distance between Glu230 and Glu257 is 
only 16.4Å and facilitates flexible interactions in this region. The density of the negative charge in the binding pocket is 
important for maintaining the sensitivity and the compensatory effect of the positive charge at substrate positions P4–P6. 
This structure was modeled based on the published 3D structure of the furin catalytic domain in complex with an inhibitor 
(Protein Data Bank ID: IP8J)[4]. The figure was generated with Swiss–Pdb Viewer[17] and was modified from the authors’ 
previous publication[5].  
 
Although these conclusions were entirely de-
rived from the theoretical 3D structure study, they 
are supported by existing experimental data. The 
cleavage site of integrin alpha 4 precursor 
(HVISKR597↓, GI_124945) lacks a positively charged 
residue at position P4, and compensates for this loss 
with a positively charged histidine at position P6 that 
is protonated in the acidic secretory compartments. 
By co-infecting furin-deficient LOVO cells with indi-
vidual proprotein convertases and measuring im-
munoprecipitated products of cleavage, Bergeron and 
co-workers showed that processing of integrin alpha 
4 precursor is performed efficiently by furin, PACE4 
and PC5 (similar specificity), and much less effi-Int. J. Biol. Sci. 2010, 6 
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ciently by PC1 (reduced sensitivity for positive 
charge at position P6), and not by PC7[10]. In another 
study, Hendy and co-workers co-expressed 
pro-parathyroid hormone and proprotein convertases 
in BSC-40 and GH4C1 cells. The mass spectrometric 
analysis indicated that the cleavage site of 
pro-parathyroid hormone (KSVKKR31↓, GI_4506267) 
can be 2–4-fold more efficiently cleaved by furin than 
PC1 and PC2[11]. Again, the pattern KSVKKR↓ is 
characterized by the efficient compensation for the 
absence of a positive charge a t  p o s i t i o n  P 4  b y  t h e  
presence of a positive charge at P6, which is pre-
served for furin, but reduced for PC1 and PC2. 
To summarize, a negatively charged density at 
position 230 and 257 is a key factor that regulates the 
substrate specificity of mammalian proprotein con-
vertases. In the course of molecular evolution, the 
enzyme function of the mammalian proprotein con-
vertase family seems to have been fine-tuned by ad-
justing the density of the negative charge of the 
binding pockets. While this mechanism is supported 
by both the theoretical approach and experimental 
data, it is not the only structural mechanism. Which 
amino acid is present at other substrate positions 
such as P1’ and P2’ and the solvent accessibility of the 
substrates also affect the cleavage efficiency. In addi-
tion, physical interaction between the substrates and 
binding pockets of proprotein convertases is not the 
only way in which cleavage is regulated; the function 
of proprotein convertases is also regulated at other 
levels such as the level of expression in different tis-
sues, their sub-cellular localizations, and the acidity 
of the different secretory compartments.   
2.3. Towards the design of specific small molecule inhibitors 
targeting furin, PACE4, PC5, PC4 and PC7 
Cleavage of proprotein convertases can be effi-
ciently inhibited by a small molecule dec-RVKR-cmk 
[18,19]. The structure of dec-RVKR-cmk is character-
ized by positively charged residues at substrate posi-
tions P1, P2 and P4. Consequently, this small mole-
cule dec-RVKR-cmk efficiently binds to all seven 
mammalian proprotein convertases, and only has 
limited use for studying the functional redundancy of 
mammalian proprotein convertases. 
Specific short peptide inhibitors for only a spe-
cific group of proprotein convertases will aid the 
study of the functional redundancy of proprotein 
convertases. The results from a comparative study of 
the 3D structure immediately suggested a novel pat-
tern for small molecule inhibitors targeting a specific 
group of mammalian proprotein convertases. The 
general 3D structure of this small molecule is similar 
to that of short peptides [K/R]-X-V-X-K-R, which 
omit a positively charged residue at position P4, but 
add a positively charged residue at position P6. The 
loss of the negative charge on Glu230 and Glu257 of 
the PC1 and PC2 binding pocket likely results in re-
duced sensitivity to the positive charge at substrate 
positions P5 and P6, whereas at least one negative 
charge is conserved at Glu230 or Glu257 in the bind-
ing pockets of the other five mammalian proprotein 
convertases: furin, PACE4, PC5, PC4 and PC7. 
Therefore, a short peptide [K/R]-X-V-X-K-R, with no 
positive charge at position P4 and one positive charge 
at position P6, should have a higher affinity to furin, 
PACE4, PC5, PC4 and PC7 than to PC1 and PC2.   
Interestingly, in the course of molecular evolu-
tion, PC1 and PC2 have acquired very different tissue 
distributions from the other five mammalian propro-
tein convertases[2]: PC1 and PC2 are highly ex-
pressed in neuroendocrine tissue; PC4 is highly ex-
pressed in the testicular and ovarian tissues; furin, 
PACE4, PC5 and PC7 are widely expressed. Given 
the different expression levels of the different mam-
malian proprotein convertases in the various tissue 
types, a small specific molecular inhibitor specifically 
targeting furin, PACE4, PC5, PC4 and PC7 would be 
especially interesting for the development of thera-
peutic applications. Various derivatives of this novel 
short peptide pattern [K/R]-X-V-X-K-R need to be 
tested for the optimal binding affinity and specificity, 
and further work is needed to confirm their potential. 
3. Materials and Methods 
3.1 Analysis of 3D structural environment of the mouse 
furin binding pocket 
The 3D crystal structure of the dec-RVKR-cmk 
inhibited mouse furin binding pocket was retrieved 
from the Protein Data Bank ID:IP8J[4]. To analyse the 
3D structure of the active site and calculate hydrogen 
bonds of molecular interactions, Swiss-PDB 
Viewer[17] was used and the procedures described 
by  Guex et al. on the Swiss-Pdb Viewer site 
http://www.expasy.org/spdbv/ were followed. 
3.2 Multiple sequence alignment of mammalian propro-
tein convertases 
The mammalian orthologues of seven propro-
tein convertases (furin, PC1/PC3/SPC3, PC2/SPC2, 
PC4/SPC5, PACE4/SPC4, PC5/PC6/SPC6 and 
PC7/PC8/SPC7/LPC) were identified by the BLAST 
algorithm[20]. Five mammal species with relatively 
well-assembled genomes were selected: Homo sapiens, 
Mus musculus, Rattus norvegicus, Bos taurus and Canis 
familiaris. A multiple sequence alignment was pro-
duced by Clustalx[6]. Int. J. Biol. Sci. 2010, 6 
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4. Conclusions 
Our results extended our previous study on the 
physical properties of a 20-residue furin cleavage mo-
tif by determining the functional consequences of 
mutations at two specific positions (230 and 257) of 
the binding pockets of the other six mammalian pro-
protein convertases. We showed that the residues at 
positions 230 and 257 are frequently mutated in the 
binding pocket of mammalian proprotein converta-
ses, resulting in a change in the density of the nega-
tive charge of the binding pockets. Comparison of the 
3D structures suggests that different proprotein con-
vertases have different sensitivities for the positive 
charge at substrate positions P5 and P6. Specifically, 
PC1 and PC2 may have reduced sensitivity for posi-
tively charged residues at the substrate position P5 or 
P6, whereas the substrate specificities of furin, 
PACE4, and PC5 may be very similar to each other. 
The density of the negative charge of the binding 
pockets seems to have played a key role in the mo-
lecular evolution of the enzyme function of the 
mammalian proprotein convertase family. This may 
allow the rational design of novel specific molecular 
inhibitors targeting specific members of the mam-
malian proprotein convertase family. 
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